Fig. 1 · Structure
Documents & Downloads
VX-759
HCV Inhibitor
VX-759 is an orally active inhibitor of the HCV NS5B RNA-dependent RNA polymerase. It effectively disrupts viral replication, making it a valuable tool in the study of chronic hepatitis C. This compound is primarily utilized in research applications focused on understanding HCV pathogenesis and developing antiviral therapies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 478025-29-5 |
| Applications | HCV Inhibitor |
| Formula | C22H27NO3S |
| Molecular Weight | 385.52 |
| Synonyms | VCH-759 |
| SMILES | O=C([C@@H]1CC[C@H](CC1)C)N(C2=C(SC(C3=CC=CC=C3)=C2)C(O)=O)C(C)C |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.